Information Provided By:
Fly News Breaks for September 24, 2019
CMD
Sep 24, 2019 | 07:26 EDT
Raymond James analyst Lawrence Keusch maintained a Market Perform rating on Cantel Medical following the company's Q4 results, which reflected a slight beat on EPS and revenue and mixed fiscal 2020 guidance. In a research note to investors, Keusch says it is important to remove the uncertainty around plans for medical water, which was unanswered on the earnings conference call, and that while management indicated it is still involved in its strategic review, he views comments as supporting a sale process with proceeds used for de-leveraging.
News For CMD From the Last 2 Days
There are no results for your query CMD